Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-09-12
2006-09-12
Kfle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S221000, C540S506000, C540S509000, C540S562000, C540S572000
Reexamination Certificate
active
07105509
ABSTRACT:
A novel class of 1,4- and 1,5-benzodiazepines of formula (I) is disclosed. The compounds modulate the processing of amyloid precursor protein by γ-secretase, and hence find use in the treatment or prevention of conditions associated with the deposition of β-amyloid, such as Alzheimer's disease
REFERENCES:
patent: 5324726 (1994-06-01), Bock et al.
patent: 5776930 (1998-07-01), Lynch, Jr. et al.
patent: 6632812 (2003-10-01), Han et al.
patent: 2004/0024203 (2004-02-01), Churcher et al.
patent: 167919 (1986-01-01), None
patent: 272865 (1998-06-01), None
patent: WO 95/14471 (1995-06-01), None
patent: WO 98/28268 (1998-07-01), None
patent: WO 00/07995 (2000-02-01), None
patent: WO 00/14073 (2000-03-01), None
patent: WO 01/19797 (2000-03-01), None
patent: WO 00/38618 (2000-07-01), None
Fryer et al. (Journal of Organic Chemistry (1977), vol. 42, No. 13, 2212-2219).
Bell et al. (Journal of Medicinal Chemistry (1968), 11(3), 457-61).
Selnick et al: Journal of Medicinal Chemistry, US, American Chemical Society. Washington, vol. 24, No. 40, 1997, pp. 3865-3868.
Rittle et al: Terahedron Letters, vol. 28, No. 5, 1987, pp. 521-525.
A Varnavas et al: Farmaco, IT, Societa Chimica Italiana, Pavia, vol. 46, No. 2, 1991, pp. 391-401.
Castro Pineiro Jose Luis
Churcher Ian
Guiblin Alexander Richard
Harrison Timothy
Kerrard Sonia
Kfle Bruck
Merck Sharp & Dohme Limited
Todaro John C.
Winokur Melvin
LandOfFree
Benzodiazepine derivatives as APP modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzodiazepine derivatives as APP modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzodiazepine derivatives as APP modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3569687